Balyasny Asset Management

Balyasny Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Balyasny Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$6.48M	Buy
2024 Q4	–	Sell
2024 Q3	$2.18M	Sell
2024 Q2	$4M	Sell
2024 Q1	$5.23M	Sell
2023 Q4	$11M	Buy
2020 Q3	–	Sell
2020 Q2	$789K	Buy